Publications by authors named "E Lacy"

How distinct mesodermal lineages - extraembryonic, lateral, intermediate, paraxial and axial - are specified from pluripotent epiblast during gastrulation is a longstanding open question. By investigating AXIN, a negative regulator of the WNT/β-catenin pathway, we have uncovered new roles for WNT signaling in the determination of mesodermal fates. We undertook complementary approaches to dissect the role of WNT signaling that augmented a detailed analysis of ; mutant mouse embryos, including single-cell and single-embryo transcriptomics, with pluripotent Epiblast-Like Cell differentiation assays.

View Article and Find Full Text PDF

The nature and origins of addictions and of their adjunctive behaviors, as well as their chronicity, call for treatments that conceptualize and treat them as the long-term and complex processes that they are. Addictions are often comorbid with personality problems and with trauma histories. Patients suffering from these disorders often show poor engagement with treatment and high rates of relapse, possibly because available treatments have yet to address the patient suffering from addiction in a more integrated or holistic manner.

View Article and Find Full Text PDF

Tension pneumothorax (TPT) identified in the prehospital setting requires prehospital needle decompression (PHND). This study aimed to evaluate complications from PHND when it was performed without meeting clinical criteria. A retrospective review was performed of patients undergoing (PHND) from 2016 through 2022 at a level 1 trauma center.

View Article and Find Full Text PDF

Third doses of COVID-19 vaccines were widely deployed following the primary vaccine course waning and the emergence of the Omicron-variant. We investigated protection from third-dose vaccines and previous infection against SARS-CoV-2 infection during Delta-variant and Omicron-variant (BA.1 & BA.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers developed a novel monoclonal antibody (mAb) called "mAbtyrin" that targets multiple bacterial processes, enhancing its effectiveness against S. aureus.
  • * mAbtyrin showed improved protection in preclinical models, including better defense against infections and enhanced effectiveness when used with vancomycin, suggesting it could be a promising treatment for S. aureus-related diseases.
View Article and Find Full Text PDF